Skip to main content
Top
Published in: European Archives of Oto-Rhino-Laryngology 4/2011

01-04-2011 | Review Article

Current concepts of organ preservation in head and neck cancer

Authors: C.-J. Wang, R. Knecht

Published in: European Archives of Oto-Rhino-Laryngology | Issue 4/2011

Login to get access

Abstract

The treatment of laryngeal and hypopharyngel cancer nowadays is not limited by surgical resection. There are many interdisciplinary approaches which we can offer these patients in our clinics. These include radiotherapy, chemotherapy, biologicals and surgery. The combination of radiotherapy, chemotherapy, biologicals and surgery techniques more and more allows us to perform organ and function preservation in a former often mutilating and function destroying treatment. Since the early 1990s, evidence from large randomized trials has shown that organ preservation studies using sequential and concomitant radio-chemotherapy do not compromise survival when compared with surgery followed by radiotherapy. However, using these therapies side effects have to be taken into consideration and not organ preservation but function preservation is the treatment goal. The current most common treatment options are shown here in this review. For future treatment protocols there is an urgent need to refine the definition of a functional organ, to define quality of life endpoints and to refine the recommendations for evaluating treatment response.
Literature
1.
go back to reference Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ (2009) Cancer statistics, 2009. CA Cancer J Clin 59(4):225–249PubMedCrossRef Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ (2009) Cancer statistics, 2009. CA Cancer J Clin 59(4):225–249PubMedCrossRef
2.
go back to reference Robert Koch-Institut GdeKiDeV (ed) (2010) Krebs in Deutschland 2005/2006—Häufigkeiten und Trends. 7 ed. Berlin: Robert Koch-Institut und die Gesellschaft der epidemiologischen Krebsregister in Deutschland e. V. Robert Koch-Institut GdeKiDeV (ed) (2010) Krebs in Deutschland 2005/2006—Häufigkeiten und Trends. 7 ed. Berlin: Robert Koch-Institut und die Gesellschaft der epidemiologischen Krebsregister in Deutschland e. V.
3.
go back to reference Holsinger FC (2008) Swing of the pendulum: optimizing functional outcomes in larynx cancer. Curr Oncol Rep 10(2):170–175PubMedCrossRef Holsinger FC (2008) Swing of the pendulum: optimizing functional outcomes in larynx cancer. Curr Oncol Rep 10(2):170–175PubMedCrossRef
4.
go back to reference Lefebvre JL (1998) Larynx preservation: the discussion is not closed. Otolaryngol Head Neck Surg 118(3 Pt 1):389–393PubMedCrossRef Lefebvre JL (1998) Larynx preservation: the discussion is not closed. Otolaryngol Head Neck Surg 118(3 Pt 1):389–393PubMedCrossRef
5.
go back to reference Pignon JP, Bourhis J, Domenge C, Designe L (2000) Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-analysis of chemotherapy on head and neck cancer. Lancet 355(9208):949–955PubMed Pignon JP, Bourhis J, Domenge C, Designe L (2000) Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-analysis of chemotherapy on head and neck cancer. Lancet 355(9208):949–955PubMed
6.
go back to reference Pignon JP, le Maitre A, Bourhis J (2007) Meta-analyses of chemotherapy in head and neck cancer (MACH-NC): an update. Int J Radiat Oncol Biol Phys 69(2 Suppl):S112–S114PubMed Pignon JP, le Maitre A, Bourhis J (2007) Meta-analyses of chemotherapy in head and neck cancer (MACH-NC): an update. Int J Radiat Oncol Biol Phys 69(2 Suppl):S112–S114PubMed
7.
go back to reference Wolf GTHW, Gross Fisher S (1991) Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer (The Department of Veterans Affairs [VA] Laryngeal Cancer Study Group). N Engl J Med 324:1685–1690CrossRef Wolf GTHW, Gross Fisher S (1991) Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer (The Department of Veterans Affairs [VA] Laryngeal Cancer Study Group). N Engl J Med 324:1685–1690CrossRef
8.
go back to reference Forastiere AA, Goepfert H, Maor M, Pajak TF, Weber R, Morrison W et al (2003) Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 349(22):2091–2098PubMedCrossRef Forastiere AA, Goepfert H, Maor M, Pajak TF, Weber R, Morrison W et al (2003) Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 349(22):2091–2098PubMedCrossRef
9.
go back to reference Olsen KD (2010) Reexamining the treatment of advanced laryngeal cancer. Head Neck 32(1):1–7PubMed Olsen KD (2010) Reexamining the treatment of advanced laryngeal cancer. Head Neck 32(1):1–7PubMed
10.
go back to reference Lefebvre JL, Chevalier D, Luboinski B, Kirkpatrick A, Collette L, Sahmoud T (1996) Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group. J Natl Cancer Inst 88(13):890–899PubMedCrossRef Lefebvre JL, Chevalier D, Luboinski B, Kirkpatrick A, Collette L, Sahmoud T (1996) Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group. J Natl Cancer Inst 88(13):890–899PubMedCrossRef
11.
go back to reference Richard JM, Sancho-Garnier H, Pessey JJ, Luboinski B, Lefebvre JL, Dehesdin D et al (1998) Randomized trial of induction chemotherapy in larynx carcinoma. Oral Oncol 34(3):224–228PubMedCrossRef Richard JM, Sancho-Garnier H, Pessey JJ, Luboinski B, Lefebvre JL, Dehesdin D et al (1998) Randomized trial of induction chemotherapy in larynx carcinoma. Oral Oncol 34(3):224–228PubMedCrossRef
12.
go back to reference Forastiere AA, Maor M, Weber RS, Pajak T, Glisson B, Trotti A et al. (2006) Long-term results of Intergroup RTOG 91-11: a phase III trial to preserve the larynx—induction cisplatin/5-FU and radiation therapy versus concurrent cisplatin and radiation therapy versus radiation therapy. ASCO Meeting Abstracts 24(18 Suppl):5517 Forastiere AA, Maor M, Weber RS, Pajak T, Glisson B, Trotti A et al. (2006) Long-term results of Intergroup RTOG 91-11: a phase III trial to preserve the larynx—induction cisplatin/5-FU and radiation therapy versus concurrent cisplatin and radiation therapy versus radiation therapy. ASCO Meeting Abstracts 24(18 Suppl):5517
13.
go back to reference Trotti A, Pajak TF, Gwede CK, Paulus R, Cooper J, Forastiere A et al (2007) TAME: development of a new method for summarising adverse events of cancer treatment by the Radiation Therapy Oncology Group. Lancet Oncol 8(7):613–624PubMedCrossRef Trotti A, Pajak TF, Gwede CK, Paulus R, Cooper J, Forastiere A et al (2007) TAME: development of a new method for summarising adverse events of cancer treatment by the Radiation Therapy Oncology Group. Lancet Oncol 8(7):613–624PubMedCrossRef
14.
go back to reference Lefebvre JL, Rolland F, Tesselaar M, Bardet E, Leemans CR, Geoffrois L et al (2009) Phase 3 randomized trial on larynx preservation comparing sequential vs alternating chemotherapy and radiotherapy. J Natl Cancer Inst 101(3):142–152PubMedCrossRef Lefebvre JL, Rolland F, Tesselaar M, Bardet E, Leemans CR, Geoffrois L et al (2009) Phase 3 randomized trial on larynx preservation comparing sequential vs alternating chemotherapy and radiotherapy. J Natl Cancer Inst 101(3):142–152PubMedCrossRef
15.
go back to reference Adelstein DJ, Rodriguez CP (2008) Current and emerging standards of concomitant chemoradiotherapy. Semin Oncol 35(3):211–220PubMedCrossRef Adelstein DJ, Rodriguez CP (2008) Current and emerging standards of concomitant chemoradiotherapy. Semin Oncol 35(3):211–220PubMedCrossRef
16.
go back to reference Forastiere AA (2008) Chemotherapy in the treatment of locally advanced head and neck cancer. J Surg Oncol 97(8):701–707PubMedCrossRef Forastiere AA (2008) Chemotherapy in the treatment of locally advanced head and neck cancer. J Surg Oncol 97(8):701–707PubMedCrossRef
17.
go back to reference Cmelak AJ, Li S, Goldwasser MA, Murphy B, Cannon M, Pinto H et al (2007) Phase II trial of chemoradiation for organ preservation in resectable stage III or IV squamous cell carcinomas of the larynx or oropharynx: results of Eastern Cooperative Oncology Group Study E2399. J Clin Oncol 25(25):3971–3977PubMedCrossRef Cmelak AJ, Li S, Goldwasser MA, Murphy B, Cannon M, Pinto H et al (2007) Phase II trial of chemoradiation for organ preservation in resectable stage III or IV squamous cell carcinomas of the larynx or oropharynx: results of Eastern Cooperative Oncology Group Study E2399. J Clin Oncol 25(25):3971–3977PubMedCrossRef
18.
go back to reference Biete Sola A, Marruecos Querol J, Calvo Manuel FA, Verger Fransoy E, Rovirosa Casino A, Grau de Castro JJ et al (2007) Phase II trial: concurrent radio-chemotherapy with weekly docetaxel for advanced squamous cell carcinoma of head and neck. Clin Transl Oncol 9(4):244–250PubMedCrossRef Biete Sola A, Marruecos Querol J, Calvo Manuel FA, Verger Fransoy E, Rovirosa Casino A, Grau de Castro JJ et al (2007) Phase II trial: concurrent radio-chemotherapy with weekly docetaxel for advanced squamous cell carcinoma of head and neck. Clin Transl Oncol 9(4):244–250PubMedCrossRef
19.
go back to reference Mantz CA, Vokes EE, Kies MS, Mittal B, Witt ME, List MA et al (2001) Sequential induction chemotherapy and concomitant chemoradiotherapy in the management of locoregionally advanced laryngeal cancer. Ann Oncol 12(3):343–347PubMedCrossRef Mantz CA, Vokes EE, Kies MS, Mittal B, Witt ME, List MA et al (2001) Sequential induction chemotherapy and concomitant chemoradiotherapy in the management of locoregionally advanced laryngeal cancer. Ann Oncol 12(3):343–347PubMedCrossRef
20.
go back to reference Pointreau Y, Garaud P, Chapet S, Sire C, Tuchais C, Tortochaux J et al (2009) Randomized trial of induction chemotherapy with cisplatin and 5-fluorouracil with or without docetaxel for larynx preservation. J Natl Cancer Inst 101(7):498–506PubMedCrossRef Pointreau Y, Garaud P, Chapet S, Sire C, Tuchais C, Tortochaux J et al (2009) Randomized trial of induction chemotherapy with cisplatin and 5-fluorouracil with or without docetaxel for larynx preservation. J Natl Cancer Inst 101(7):498–506PubMedCrossRef
21.
go back to reference Posner MR, Norris CM, Wirth LJ, Shin DM, Cullen KJ, Winquist EW et al (2009) Sequential therapy for the locally advanced larynx and hypopharynx cancer subgroup in TAX 324: survival, surgery, and organ preservation. Ann Oncol 20(5):921–927PubMedCrossRef Posner MR, Norris CM, Wirth LJ, Shin DM, Cullen KJ, Winquist EW et al (2009) Sequential therapy for the locally advanced larynx and hypopharynx cancer subgroup in TAX 324: survival, surgery, and organ preservation. Ann Oncol 20(5):921–927PubMedCrossRef
22.
go back to reference Posner MR, Lorch JH, Goloubeva O, Tan M, Schumaker L, Sarlis NJ et al. (2010) Oropharynx cancer (OPC) in TAX 324: Human papillomavirus (HPV) and survival. ASCO Meeting Abstracts 28(15 Suppl):5525 Posner MR, Lorch JH, Goloubeva O, Tan M, Schumaker L, Sarlis NJ et al. (2010) Oropharynx cancer (OPC) in TAX 324: Human papillomavirus (HPV) and survival. ASCO Meeting Abstracts 28(15 Suppl):5525
23.
go back to reference Lorch JH, Posner MR, Goloubeva O, Cullen KJ, Sarlis NJ, Tishler RB et al. (2010) Long-term results from TAX324: a phase III trial of sequential therapy comparing TPF to PF in locally advanced (LA) squamous cell cancer of the head and neck (HNC). ASCO Meeting Abstracts 28(15 Suppl):5512 Lorch JH, Posner MR, Goloubeva O, Cullen KJ, Sarlis NJ, Tishler RB et al. (2010) Long-term results from TAX324: a phase III trial of sequential therapy comparing TPF to PF in locally advanced (LA) squamous cell cancer of the head and neck (HNC). ASCO Meeting Abstracts 28(15 Suppl):5512
24.
go back to reference Vermorken JB, Remenar E, van Herpen C, Gorlia T, Mesia R, Degardin M et al (2007) Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer. N Engl J Med 357(17):1695–1704PubMedCrossRef Vermorken JB, Remenar E, van Herpen C, Gorlia T, Mesia R, Degardin M et al (2007) Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer. N Engl J Med 357(17):1695–1704PubMedCrossRef
25.
go back to reference Goodwin WJ Jr (2000) Salvage surgery for patients with recurrent squamous cell carcinoma of the upper aerodigestive tract: when do the ends justify the means? Laryngoscope 110(3 Pt 2 Suppl 93):1–18PubMedCrossRef Goodwin WJ Jr (2000) Salvage surgery for patients with recurrent squamous cell carcinoma of the upper aerodigestive tract: when do the ends justify the means? Laryngoscope 110(3 Pt 2 Suppl 93):1–18PubMedCrossRef
26.
go back to reference Pomerantz RG, Grandis JR (2004) The epidermal growth factor receptor signaling network in head and neck carcinogenesis and implications for targeted therapy. Semin Oncol 31(6):734–743PubMedCrossRef Pomerantz RG, Grandis JR (2004) The epidermal growth factor receptor signaling network in head and neck carcinogenesis and implications for targeted therapy. Semin Oncol 31(6):734–743PubMedCrossRef
27.
go back to reference Bonner JA, Harari PM, Giralt J, Azarnia N, Shin DM, Cohen RB et al (2006) Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med 354(6):567–578PubMedCrossRef Bonner JA, Harari PM, Giralt J, Azarnia N, Shin DM, Cohen RB et al (2006) Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med 354(6):567–578PubMedCrossRef
28.
go back to reference Brumund KT, Gutierrez-Fonseca R, Garcia D, Babin E, Hans S, Laccourreye O (2005) Frontolateral vertical partial laryngectomy without tracheotomy for invasive squamous cell carcinoma of the true vocal cord: a 25-year experience. Ann Otol Rhinol Laryngol 114(4):314–322PubMed Brumund KT, Gutierrez-Fonseca R, Garcia D, Babin E, Hans S, Laccourreye O (2005) Frontolateral vertical partial laryngectomy without tracheotomy for invasive squamous cell carcinoma of the true vocal cord: a 25-year experience. Ann Otol Rhinol Laryngol 114(4):314–322PubMed
29.
go back to reference Dufour X, Hans S, De Mones E, Brasnu D, Menard M, Laccourreye O (2004) Local control after supracricoid partial laryngectomy for “advanced” endolaryngeal squamous cell carcinoma classified as T3. Arch Otolaryngol Head Neck Surg 130(9):1092–1099PubMedCrossRef Dufour X, Hans S, De Mones E, Brasnu D, Menard M, Laccourreye O (2004) Local control after supracricoid partial laryngectomy for “advanced” endolaryngeal squamous cell carcinoma classified as T3. Arch Otolaryngol Head Neck Surg 130(9):1092–1099PubMedCrossRef
30.
go back to reference Tufano RP (2002) Organ preservation surgery for laryngeal cancer. Otolaryngol Clin North Am 35(5):1067–1080PubMedCrossRef Tufano RP (2002) Organ preservation surgery for laryngeal cancer. Otolaryngol Clin North Am 35(5):1067–1080PubMedCrossRef
31.
go back to reference Sheen TS, Ko JY, Chang YL (1998) Partial vertical laryngectomy in the treatment of early glottic cancer. Ann Otol Rhinol Laryngol 107(7):593–597PubMed Sheen TS, Ko JY, Chang YL (1998) Partial vertical laryngectomy in the treatment of early glottic cancer. Ann Otol Rhinol Laryngol 107(7):593–597PubMed
32.
go back to reference Yeager LB, Grillone GA (2005) Organ preservation surgery for intermediate size (T2 and T3) laryngeal cancer. Otolaryngol Clin North Am 38(1):11–20 viiPubMedCrossRef Yeager LB, Grillone GA (2005) Organ preservation surgery for intermediate size (T2 and T3) laryngeal cancer. Otolaryngol Clin North Am 38(1):11–20 viiPubMedCrossRef
33.
go back to reference Wein RO, Weber RS (2005) The current role of vertical partial laryngectomy and open supraglottic laryngectomy. Curr Probl Cancer 29(4):201–214PubMedCrossRef Wein RO, Weber RS (2005) The current role of vertical partial laryngectomy and open supraglottic laryngectomy. Curr Probl Cancer 29(4):201–214PubMedCrossRef
34.
go back to reference Strong MS, Jako GJ (1972) Laser surgery in the larynx. Early clinical experience with continuous CO 2 laser. Ann Otol Rhinol Laryngol 81(6):791–798PubMed Strong MS, Jako GJ (1972) Laser surgery in the larynx. Early clinical experience with continuous CO 2 laser. Ann Otol Rhinol Laryngol 81(6):791–798PubMed
35.
go back to reference Steiner W, Ambrosch P, Hess CF, Kron M (2001) Organ preservation by transoral laser microsurgery in piriform sinus carcinoma. Otolaryngol Head Neck Surg 124(1):58–67PubMedCrossRef Steiner W, Ambrosch P, Hess CF, Kron M (2001) Organ preservation by transoral laser microsurgery in piriform sinus carcinoma. Otolaryngol Head Neck Surg 124(1):58–67PubMedCrossRef
36.
go back to reference Ambrosch P, Kron M, Steiner W (1998) Carbon dioxide laser microsurgery for early supraglottic carcinoma. Ann Otol Rhinol Laryngol 107(8):680–688PubMed Ambrosch P, Kron M, Steiner W (1998) Carbon dioxide laser microsurgery for early supraglottic carcinoma. Ann Otol Rhinol Laryngol 107(8):680–688PubMed
37.
go back to reference Steiner W, Fierek O, Ambrosch P, Hommerich CP, Kron M (2003) Transoral laser microsurgery for squamous cell carcinoma of the base of the tongue. Arch Otolaryngol Head Neck Surg 129(1):36–43PubMedCrossRef Steiner W, Fierek O, Ambrosch P, Hommerich CP, Kron M (2003) Transoral laser microsurgery for squamous cell carcinoma of the base of the tongue. Arch Otolaryngol Head Neck Surg 129(1):36–43PubMedCrossRef
38.
go back to reference Ambrosch P (2007) The role of laser microsurgery in the treatment of laryngeal cancer. Curr Opin Otolaryngol Head Neck Surg 15(2):82–88PubMedCrossRef Ambrosch P (2007) The role of laser microsurgery in the treatment of laryngeal cancer. Curr Opin Otolaryngol Head Neck Surg 15(2):82–88PubMedCrossRef
39.
go back to reference O’Malley BW Jr, Weinstein GS, Snyder W, Hockstein NG (2006) Transoral robotic surgery (TORS) for base of tongue neoplasms. Laryngoscope 116(8):1465–1472PubMedCrossRef O’Malley BW Jr, Weinstein GS, Snyder W, Hockstein NG (2006) Transoral robotic surgery (TORS) for base of tongue neoplasms. Laryngoscope 116(8):1465–1472PubMedCrossRef
40.
go back to reference Weinstein GS, O’Malley BW Jr, Snyder W, Sherman E, Quon H (2007) Transoral robotic surgery: radical tonsillectomy. Arch Otolaryngol Head Neck Surg 133(12):1220–1226PubMedCrossRef Weinstein GS, O’Malley BW Jr, Snyder W, Sherman E, Quon H (2007) Transoral robotic surgery: radical tonsillectomy. Arch Otolaryngol Head Neck Surg 133(12):1220–1226PubMedCrossRef
41.
go back to reference Weinstein GS, O’Malley BW Jr, Snyder W, Hockstein NG (2007) Transoral robotic surgery: supraglottic partial laryngectomy. Ann Otol Rhinol Laryngol 116(1):19–23PubMed Weinstein GS, O’Malley BW Jr, Snyder W, Hockstein NG (2007) Transoral robotic surgery: supraglottic partial laryngectomy. Ann Otol Rhinol Laryngol 116(1):19–23PubMed
42.
go back to reference Silver CE, Beitler JJ, Shaha AR, Rinaldo A, Ferlito A (2009) Current trends in initial management of laryngeal cancer: the declining use of open surgery. Eur Arch Otorhinolaryngol 266(9):1333–1352PubMedCrossRef Silver CE, Beitler JJ, Shaha AR, Rinaldo A, Ferlito A (2009) Current trends in initial management of laryngeal cancer: the declining use of open surgery. Eur Arch Otorhinolaryngol 266(9):1333–1352PubMedCrossRef
43.
go back to reference Cooper JS, Porter K, Mallin K, Hoffman HT, Weber RS, Ang KK et al (2009) National Cancer Database report on cancer of the head and neck: 10-year update. Head Neck 31(6):748–758PubMedCrossRef Cooper JS, Porter K, Mallin K, Hoffman HT, Weber RS, Ang KK et al (2009) National Cancer Database report on cancer of the head and neck: 10-year update. Head Neck 31(6):748–758PubMedCrossRef
44.
go back to reference Chen AY, Schrag N, Hao Y, Stewart A, Ward E (2007) Changes in treatment of advanced oropharyngeal cancer, 1985–2001. Laryngoscope 117(1):16–21PubMedCrossRef Chen AY, Schrag N, Hao Y, Stewart A, Ward E (2007) Changes in treatment of advanced oropharyngeal cancer, 1985–2001. Laryngoscope 117(1):16–21PubMedCrossRef
45.
go back to reference Hoffman HT, Porter K, Karnell LH, Cooper JS, Weber RS, Langer CJ et al (2006) Laryngeal cancer in the United States: changes in demographics, patterns of care, and survival. Laryngoscope 116(9 Pt 2 Suppl 111):1–13PubMedCrossRef Hoffman HT, Porter K, Karnell LH, Cooper JS, Weber RS, Langer CJ et al (2006) Laryngeal cancer in the United States: changes in demographics, patterns of care, and survival. Laryngoscope 116(9 Pt 2 Suppl 111):1–13PubMedCrossRef
46.
go back to reference Chen AY, Halpern M (2007) Factors predictive of survival in advanced laryngeal cancer. Arch Otolaryngol Head Neck Surg 133(12):1270–1276PubMedCrossRef Chen AY, Halpern M (2007) Factors predictive of survival in advanced laryngeal cancer. Arch Otolaryngol Head Neck Surg 133(12):1270–1276PubMedCrossRef
47.
go back to reference Bosetti C, Bertuccio P, Levi F, Lucchini F, Negri E, La Vecchia C (2008) Cancer mortality in the European Union, 1970–2003, with a joinpoint analysis. Ann Oncol 19(4):631–640PubMedCrossRef Bosetti C, Bertuccio P, Levi F, Lucchini F, Negri E, La Vecchia C (2008) Cancer mortality in the European Union, 1970–2003, with a joinpoint analysis. Ann Oncol 19(4):631–640PubMedCrossRef
48.
go back to reference La Vecchia C, Bosetti C, Lucchini F, Bertuccio P, Negri E, Boyle P et al (2009) Cancer mortality in Europe, 2000–2004, and an overview of trends since 1975. Ann Oncol 21(6):1323–1360 La Vecchia C, Bosetti C, Lucchini F, Bertuccio P, Negri E, Boyle P et al (2009) Cancer mortality in Europe, 2000–2004, and an overview of trends since 1975. Ann Oncol 21(6):1323–1360
49.
go back to reference Pfister DG, Laurie SA, Weinstein GS, Mendenhall WM, Adelstein DJ, Ang KK et al (2006) American Society of Clinical Oncology clinical practice guideline for the use of larynx-preservation strategies in the treatment of laryngeal cancer. J Clin Oncol 24(22):3693–3704PubMedCrossRef Pfister DG, Laurie SA, Weinstein GS, Mendenhall WM, Adelstein DJ, Ang KK et al (2006) American Society of Clinical Oncology clinical practice guideline for the use of larynx-preservation strategies in the treatment of laryngeal cancer. J Clin Oncol 24(22):3693–3704PubMedCrossRef
Metadata
Title
Current concepts of organ preservation in head and neck cancer
Authors
C.-J. Wang
R. Knecht
Publication date
01-04-2011
Publisher
Springer-Verlag
Published in
European Archives of Oto-Rhino-Laryngology / Issue 4/2011
Print ISSN: 0937-4477
Electronic ISSN: 1434-4726
DOI
https://doi.org/10.1007/s00405-010-1407-8

Other articles of this Issue 4/2011

European Archives of Oto-Rhino-Laryngology 4/2011 Go to the issue